On September 22, 2025, President Donald J. Trump, along with administration officials, shared significant developments regarding autism and the potential risks associated with acetaminophen use during pregnancy.
• President Trump’s administration promotes new health guidance emphasizing the possible link between prenatal acetaminophen use and autism spectrum disorder (ASD).
• Press Secretary Karoline Leavitt noted the administration's commitment to addressing autism rates, asserting that not all health issues necessitate medication.
• Studies, such as the Nurses’ Health Study II and the Boston Birth Cohort, indicate a connection between acetaminophen taken during pregnancy and increased risks of ASD and ADHD in children.
• Renowned institutions like Harvard and Johns Hopkins University support claims that acetaminophen may adversely affect brain development in infants.
• An international consensus suggests pregnant women should limit acetaminophen use to the lowest effective dose for the shortest time necessary.
The Trump administration's new initiatives are aimed at understanding and addressing autism, driven by compelling research linking prenatal medication use to neurological effects in children.
No comments:
Post a Comment